Patient capital,
deliberately deployed &
research-led.

Alchemy Opus Capital is a privately held family investment group, allocating across global equities, real estate, advanced technology and the life sciences — guided by rigorous research and an unwavering preference for risk-adjusted, long-horizon return.

Discover

01 — The Firm

A privately held family investment group.

Alchemy Opus Capital invests across an extensive range of sectors — including finance, real estate, manufacturing, artificial intelligence, biotechnology, scientific research, and the hospitality and consumer industries.

Our balance sheet spans listed and unlisted equities (domestic and foreign), sovereign and corporate debt, commodities — from precious and industrial metals to agricultural staples and energy — derivatives instruments, residential and commercial real estate, and a curated holding of fine collectibles including artworks, rare coins, vintage wine and philately.

We pursue capital growth with disciplined risk control as our first principle, calibrating each strategy to optimise both short and long-horizon return.

— 01

Multi-Asset

Cohesive allocation across asset classes, geographies and market regimes — engineered for resilience, not for noise.

— 02

Frontier Technology

Concentrated conviction in advanced artificial intelligence, computation and the platforms shaping the next decade of productivity.

— 03

Original Research

Independent, primary research is the foundation of every position — the lens through which we read sectors, cycles and structural change.

— 04

Next-Generation Biotech

Sustained capital commitment to next-generation biologics — therapeutics, platforms and the science that may redefine longevity.

02 — Our People

The strongest competitive advantage we hold.

Our team draws elites from leading global universities, with deep operating experience across mergers and acquisitions, venture and private equity, quantitative analysis and legal advisory. Behind us stand multiple investment groups and seasoned investors. We share one conviction — that unlocking the full potential of an exceptional business is rewarding work, and powerful work.

Stanford

UC Berkeley

Pennsylvania

Carnegie Mellon

Disciplines Across The Group

Mergers & Acquisitions Venture & Private Equity Quantitative Analysis Legal Advisory

03 — Correspondence

Begin a conversation.

For partnership, allocation or research enquiries, our offices welcome direct correspondence in confidence.

— I

Road Town

British Virgin Islands

— II

George Town

Cayman Islands

— III

Hong Kong

Greater China

— IV

Castries

Saint Lucia

Considered enquiries, thoughtfully answered.

We welcome direct correspondence from prospective partners, founders and allocators. Please share a few lines about the nature of your enquiry and a member of our team will respond.

Generalenquiries@alchemyopus.com
Presspress@alchemyopus.com
HoursMonday to Friday · By appointment

Patient capital, deliberately deployed & research-led.